|
Session 161
Poster Abstracts
Immune Response to HIV and Protective Vaccines in Children
Tuesday, 1-2:30 pm
Poster Hall |
895
 |
Quantitative T Cell Repertoire Spectra-type Analysis Reveals Evidence of Persistent T Cell Receptor Perturbation in Aviremic Perinatally Infected Adolescents and Adults
Diana Chen*1, O Yang1, B Arumugam1, M Belzer2, J Church2, K Nielsen-Saines1, J Deville1, and P Krogstad1
1David Geffen Sch of Med, Univ of California, Los Angeles Med Ctr, US and 2Children`s Hosp Los Angeles and Keck Sch of Med at Univ of Southern California, US |
| 896 |
Early Induction of CD4+ Naïve T Cells and Retention of Innate Effectors in Highly Viremic Perinatally HIV-infected Infants
Emmanouil Papasavvas*1, L Azzoni1, A Violari2, M Cotton3, D Lawrie2, D Glencross2, W Stevens2, J McIntyre2, C Tiemessen4, and L Montaner1
1Wistar Inst, Philadelphia, PA, US; 2Univ of the Witwatersrand, Johannesburg, South Africa; 3Tygerberg Children`s Hosp, Stellenbosch Univ, Cape Town, South Africa; and 4Natl Inst for Communicable Diseases, Johannesburg, South Africa |
| 897 |
Factors Associated with Robust Antibody Responses to the Hepatitis A Virus Vaccine in HIV-infected Children: International Maternal Pediatric Adolescent AIDS Clinical Trials, P1008
Adriana Weinberg*1, S Huang2, T Fenton2, J Patterson-Bartlett1, P Gona3, J Read4, W Dankner5, S Nachman6, and IMPAACT P1008 Team
1Univ of Colorado Denver Sch of Med, US; 2Statistical and Data Analysis Ctr, Harvard Sch of Publ Hlth, Boston, MA, US; 3Boston Univ, MA, US; 4Natl Inst of Child Hlth and Human Devt, NIH, Bethesda, MD, US; 5Duke Univ, Durham, NC, US; and 6State Univ of New York Hlth Sci Ctr at Stony Brook, US |
898
|
Immunogenicity of Quadrivalent Meningococcal Vaccine in HIV-infected Youth
George Siberry*1, J Lujan-Zilberman2, P Williams3, M Warshaw3, M Decker4, B Heckman5, E Demske6, J Read1, P Jean-Philippe7, S Nachman8, and IMPAACT Network P1065 Protocol Team
1Natl Inst of Child Hlth and Human Devt, NIH, Bethesda, MD, US; 2Univ of South Florida Coll of Med, Tampa, US; 3Harvard Sch of Publ Hlth, Boston, MA, US; 4Sanofi Pasteur Inc, Swiftwater, PA, US; 5Frontier Sci & Tech Res Fndn, Amherst, NY, US; 6Social & Sci Systems Inc, Silver Spring, MD, US; 7Henry M Jackson Fndn, Div of AIDS, NIAID, NIH, Bethesda, MD, US; and 8State Univ of New York at Stony Brook, US |
899a
|
Innate and Adaptive Immunity in Treatment-naive HIV-infected Pediatric Patients: Chennai, India
A Selvaraj1, Soumya Swaminathan*1, S Pilakka-Kanthikeel2, K Arheart2, and S Pahwa2
1TB Res Ctr, Chennai, India and 2Devt Ctr for AIDS Res, Univ of Miami, Miller Sch of Med, FL, US |
899b
|
Universal HIV Testing of Infants at Immunization Clinics in High HIV Prevalence Settings: Acceptable, Feasible, and Potential for High Returns
Nigel Rollins*1,2, S Mzolo1, T Moodley3, T Esterhuizen4, and H van Rooyen5
1Univ of KwaZulu-Natal, Durban, South Africa; 2WHO, Geneva, Switzerland; 3Futuristic Training Solutions, Durban, South Africa; 4Univ of KwaZulu-Natal, Coll of Hlth Sci, Durban, South Africa; and 5Child, Youth, Family and Social Devt, Human Sci Res Council, Durban, South Africa |
|
